Glucocorticosteroids for liver transplanted patients

  • Protocol
  • Intervention

Authors

  • Gero Langer,

    Corresponding author
    1. Martin Luther University Halle-Wittenberg, Institute for Health and Nursing Science, German Center for Evidence-based Nursing, Halle/Saale, Germany
    • Gero Langer, Institute for Health and Nursing Science, German Center for Evidence-based Nursing, Martin Luther University Halle-Wittenberg, Magdeburger Strasse 8, Halle/Saale, 06097, Germany. gero.langer@medizin.uni-halle.de.

    Search for more papers by this author
  • Susanne Saal,

    1. Martin Luther University Halle-Wittenberg, Institute for Health and Nursing Science, Halle/Saale, Germany
    Search for more papers by this author
  • Katja Großmann,

    1. German Center for Evidence-based Nursing, Martin Luther University Halle-Wittenberg, Institute for Health and Nursing Science, Halle/Saale, Germany
    Search for more papers by this author
  • Dirk Grothues,

    1. University Hospital Regensburg, Klinik und Poliklinik für Kinder- und Jugendmedizin, Regensburg, Germany
    Search for more papers by this author
  • Andreas Wienke

    1. Martin Luther University Halle-Wittenberg, Institute of Medical Epidemiology, Biostatistics and Informatics, Halle (Saale), Germany
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the benefits and harms of glucocorticosteroids for liver-transplanted patients.